Abstracts tagged "dermatomyositis and juvenile dermatomyositis"

Abstract Number: 1374 • 2016 ACR/ARHP Annual Meeting
Predictors of Changes in Disease Activity Among Children with Juvenile Dermatomyositis
Cynthia S. Crowson¹, Jeannette M. Olazagasti Lourido², Timothy B. Niewold³, Ann M Reed⁴ and CARRA Investigators, ¹Health Sciences Research, Mayo Clinic, Rochester, MN, ²University of Puerto Rico, San Juan, Puerto Rico, ³Rheumatology and Immunology, Mayo Clinic, Rochester, MN, ⁴Rheumatology, Duke University, Durham, NC
Background/Purpose: Determinants of changes in disease activity among patients with juvenile dermatomyositis (JDM) are unknown. Our objective was to develop scores to predict changes in…
Abstract Number: 1316 • 2014 ACR/ARHP Annual Meeting
A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials
Lisa G. Rider¹, Rohit Aggarwal², Nastaran Bayat¹, Brian Erman³, Brian M. Feldman⁴, Adam M. Huber⁵, Rolando Cimaz⁶, Rubén J. Cuttica⁷, Sheila K. Feitosa de Oliveira⁸, Carol B. Lindsley⁹, Clarissa A Pilkington¹⁰, Marilynn G. Punaro¹¹, Angelo Ravelli¹², Ann M. Reed¹³, Kelly A. Rouster-Stevens¹⁴, Annet van Royen-Kerkhof¹⁵, Luca Villa¹⁶, Mariangela Rinaldi¹⁶, Angela Pistorio¹⁷, Howard Rockette¹⁸, Peter A. Lachenbruch¹, Frederick W. Miller¹, Jiri Vencovsky¹⁹ and Nicolino Ruperto²⁰, ¹Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, ²Medicine, University of Pittsburgh, Pittsburgh, PA, ³Social and Scientific Systems, Inc., Durham, NC, ⁴Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁵IWK Health Centre, Halifax, NS, Canada, ⁶Pediatrics, University of Firenze, Firenze, Italy, ⁷Hospital de Niños Pedro de Elizalde - University of Buenos Aires, Buenes Aires, Argentina, ⁸Pediatric Rheumatology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, ⁹Dept of Pediatrics/ PTD, Univ Kansas City Med Ctr, Kansas City, KS, ¹⁰Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ¹¹Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, ¹²University of Genova, Genova, Italy, ¹³Rheumatology, Mayo Clinic, Rochester, MN, ¹⁴Pediatrics, Emory University School of Medicine, Atlanta, GA, ¹⁵Paediatric Immunology and Rheumatology, University Medical Centre Utrecht - Wilhelmina Children's Hospital, Utrecht, Netherlands, ¹⁶Pediatria II, Reumatologia, PRINTO, IRCCS Istituto G. Gaslini, Genova, Italy, ¹⁷Istituto Giannina Gaslini, Genova, Italy, ¹⁸University of Pittsburgh, Pittsburgh, PA, ¹⁹Institute of Rheumatology, Charles University, Prague, Czech Republic, ²⁰Pediatria II,, Istituto Giannina Gaslini, Genoa, Italy
Background/Purpose: Preliminary definitions of improvement (DOIs) for juvenile dermatomyositis (JDM) combining IMACS or PRINTO core set activity measures (CSMs) have been used as a…
Abstract Number: 2071 • 2013 ACR/ARHP Annual Meeting
Adipokines Contribute To The Inflammatory Response In Adult and Juvenile Myositis
Molly S. Hein¹, Cynthia S. Crowson², Helen Khun², Consuelo Lopez de Padilla³, Erik J. Peterson⁴, Emily Baechler⁵ and Ann M. Reed¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology/Immunology Research, Mayo Clinic, Rochester, MN, ⁴Medicine/Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, ⁵Medicine, University of Minnesota, Minneapolis, MN
Background/Purpose: Recently adipokines have been implicated for their role in regulating immune and inflammatory responses in autoimmune disease. To test the hypothesis that adipokines are…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].